Viewing Study NCT00992160


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-04-13 @ 9:21 PM
Study NCT ID: NCT00992160
Status: COMPLETED
Last Update Posted: 2016-10-28
First Post: 2009-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vestipitant 28-day Tolerance Study
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Annotation Module